Asking your doctor or researching alone, compared for Wentzville
Two routes to a depression treatment decision compared on speed, cost, oversight, records and format, plus a middle route most people miss.
There are two ways people chase a depression treatment they have just heard about. One runs through a physician; the other runs through a search bar and a clinic's intake form. Both end in a decision, and they are not equally likely to end in a good one.
Our survey, answered by 443 adults from ten Midwest states, measured which route people prefer and why. This comparison sets the two side by side for anyone in Wentzville or elsewhere in St. Charles County deciding how to start. The percentages are final.
Route one: through your physician
You raise it at an appointment. Your doctor weighs your medication history, rules things in or out, and prescribes, refers, or explains why not.
This is the route people say they want: the family doctor is where 56 percent of respondents would begin, and a psychiatrist or therapist is where 23 percent would. Together, more than three quarters would enter through a clinician rather than alone. It is also the route that changes minds. Their own doctor's recommendation would move 74 percent to try ketamine or esketamine therapy, with family and friends a distant second at 18 percent.
Route two: on your own
You search, read, find a clinic or online prescriber, and book directly. Twelve percent of respondents said they would do this, 1 percent would lean on a friend, and 5 percent admitted to being lost from the start.
It is faster to start, skipping the wait for an appointment and a referral. It also skips the person who knows your blood pressure history and every medication you have taken since 2019.
Comparing on speed
Self-directed wins outright. A clinic with open intake can often see you within days, while a primary care appointment may be weeks away and a psychiatry referral longer. But speed to a first appointment is not speed to the right treatment. If you pursue something you are not a candidate for, the time you saved gets spent twice.
Comparing on cost and coverage
Here the routes separate most sharply, and the survey is emphatic. Coverage appeared in 85 percent of respondents' top two provider factors, and for 65 percent, insurance would make or break the decision to go forward.
Physician-led care is likelier to run through benefits, because prior authorization usually needs documented medication trials that live in a medical record. Self-directed care, especially from direct-to-consumer services, is more often cash. People know this and mostly choose accordingly: asked to choose insured care that comes with extra steps or a quicker start paid out of pocket, 51 percent picked the steps, with paying taking 23 percent and indecision 26.
The payer mix underlines it. With several answers allowed, commercial coverage came to 39 percent and Medicaid 37; Medicare, no insurance, and TRICARE followed at 23, 9, and 5 percent. For much of the region, a cash-only path is simply out of reach.
Comparing on safety and oversight
Here the routes are not really comparable, because they can lead to different products. Spravato, the esketamine spray, has an FDA approval for treatment-resistant depression that comes with supervision at certified sites and monitoring after each dose, so reaching it usually takes a prescriber and a certified clinic. Ketamine used off label, from clinic infusions to home deliveries by online services, operates under different oversight, and a self-directed search surfaces all of them mixed together. Brain Recovery Centers offers an overview of supervised Spravato care that shows what the approved route looks like.
Respondents cared about that distinction even without the name for it. FDA approval mattered decisively or heavily to 59 percent, yet Spravato was a blank to 73 percent and merely a name to 21, with 6 percent actually familiar. High demand for regulatory standing plus low awareness of which product has it is exactly the gap a physician fills.
Comparing on what happens to your records
Physician-led care leaves a trail: your trials, response, side effects, and dosing sit in one chart that follows you across clinics and plans. Self-directed care often creates a parallel record your primary care office never sees, which becomes a problem when a new prescriber needs to know what you have tried and the only source is your memory.
Comparing on format
Either route can involve in-person or remote care, but respondents leaned toward the clinic: 44 percent preferred being seen in person, 22 percent telehealth at home, 23 percent a clinic start with a later shift home, and 11 percent had no preference. For Wentzville residents, in person also means the drive, the monitoring time, and a ride home, logistics that favor a site you can reach without rearranging a whole day.
A middle route most people miss
The two paths are not exclusive. Research on your own until you can describe the problem precisely, then take that research to a clinician rather than an order form.
- Write your medication timeline before the appointment: drug, dose, duration, and why it ended.
- Ask whether your history meets criteria for treatment-resistant depression, and what comes next if it does not yet.
- Ask which specific treatment is being discussed and whether it holds FDA approval for your diagnosis.
- Before committing to a clinic, ask your plan about prior authorization and which certified sites it covers.
- Whatever you pursue, make sure a copy lands in your primary care record.
Start from your own words, too. The 319 respondents who told us their search terms wrote things like "help with depression," "ptsd help," and "depression medicine alternatives." Ordinary language is where this begins for nearly everyone, and it works fine with a doctor.
This compares decision paths, not clinical options, and recommends no treatment. Only a clinician who knows your history can judge what is right for you.
One thing outranks every comparison above. Should depression turn your thoughts toward suicide, set the plan aside and reach out now. A trained person listens at 988, by call or text, free, day or night.
Methodology
The research was a Pollfish consumer panel survey that this publisher commissioned and funded. When fieldwork ended on June 23, 2026, the count was 443 completed questionnaires; respondents were 18 to 64, came from ten Midwest states, were recruited from the general public rather than screened for a diagnosis, and consented first. On multi-select questions the parts can add to more than 100 because each is a share of respondents. Results are drawn from the panel's final validation.